Jan 28, 2019
Pulmatrix, Inc. Announces Proposed Public Offering of Common Stock
Nov 15, 2018
Pulmatrix to Present Results from the Pulmazole (PUR1900) Phase 1/1b Study at the 2018 Annual Scientific Meeting of the American College of Allergy, Asthma, and Immunology
Sep 17, 2018
Pulmatrix to present pre-clinical data on PUR1800 (RV1162) at the European Respiratory Society International Congress
Apr 13, 2018
Free Research Reports on These Biotech Stocks -- Prothena, PTC Therapeutics, Pulmatrix, and Puma Biotech
Mar 29, 2018
Pulmatrix Announces Pricing Of $15.2 Million Underwritten Public Offering
Feb 12, 2018
Pulmatrix Announces First Subject Dosed in Phase 1 Clinical Trial of Pulmazole - an Inhaled Dry-Powder iSPERSE(TM) Formulation of Itraconazole
Jan 24, 2018
Pulmatrix Will Present Pulmazole Preclinical Data at the 8th Advances Against Aspergillosis Conference to be Held February 1 - 3, 2018
Jan 22, 2018
Pulmatrix Announces Acceptance of a Clinical Trial Application in Europe for Pulmazole - an Inhaled Dry-Powder iSPERSE(TM) Formulation of Itraconazole
Nov 09, 2017
Pulmatrix Provides Q3 2017 Highlights and Q3 2017 Updated Financials
Oct 31, 2017
Pulmatrix Presents at the North American Cystic Fibrosis Conference
Oct 30, 2017
Pulmatrix Appoints Dr. James Roach as Chief Medical Officer
Oct 03, 2017
Pulmatrix Antifungal Drug Candidate Receives a Second "Qualified Infectious Disease Product" (QIDP) Designation from the FDA
Sep 21, 2017
Pulmatrix to Present at the Cantor Fitzgerald Global Healthcare Conference on September 27, 2017
Sep 20, 2017
Pulmatrix Receives Key Patents on its Inhaled Drug Delivery Technology and its COPD Drug
Sep 06, 2017
Pulmatrix Licenses Inhaled COPD Drug PUR0200 to Vectura Group plc
Sep 05, 2017
Pulmatrix Receives Award from Cystic Fibrosis Foundation Therapeutics to Support Development of PUR1900 for the Treatment of Pulmonary Fungal Infections
Aug 24, 2017
Daily Technical Summary Reports on Biotech Stocks -- Paratek Pharma, Pulmatrix, Verastem, and Biostage
Aug 04, 2017
Pulmatrix Provides 2017 Company Year-to-Date Highlights and Q2 2017 Updated Financials
Jun 13, 2017
Technical Reports on Biotech Equities -- Amgen, Pulmatrix, Argos Therapeutics, and Bioverativ